Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

JDOC vs HRTS overlap: 56% of top holdings shared

Bottom line

How much do JDOC and HRTS overlap?

56% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 55.0% of JDOC's assets and 54.4% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

JDOCHRTS
Weight overlap (top 25)56%
Shared holdings14
Weight in shared holdings55.0%54.4%
Total positions6145
Expense ratio0.65%0.75%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings JDOC and HRTS have in common

Holding% of JDOC% of HRTSOverlap
AbbVie, Inc.7.85%2.40%2.40%
Eli Lilly & Co.7.76%11.52%7.76%
UnitedHealth Group, Inc.5.85%5.24%5.24%
Merck & Co., Inc.4.82%4.27%4.27%
Johnson & Johnson4.82%3.59%3.59%
AstraZeneca plc3.76%4.00%3.76%
Thermo Fisher Scientific, Inc.3.73%3.97%3.73%
Bristol-Myers Squibb Co.3.57%2.09%2.09%
Abbott Laboratories3.11%2.61%2.61%
Novo Nordisk A/S2.61%5.24%2.61%
Danaher Corp.2.16%2.66%2.16%
Edwards Lifesciences Corp.1.73%1.75%1.73%
Regeneron Pharmaceuticals, Inc.1.60%1.67%1.60%
Novartis AG1.60%3.38%1.60%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in JDOC

  1. CVS Health Corp. — 2.83%
  2. Roche Holding AG — 2.82%
  3. GSK plc — 2.47%
  4. Stryker Corp. — 2.23%
  5. Cencora, Inc. — 2.07%
  6. Argenx SE — 2.06%
  7. Intuitive Surgical, Inc. — 1.93%
  8. IQVIA Holdings, Inc. — 1.71%
  9. Teva Pharmaceutical Industries Ltd. — 1.60%
  10. Biogen, Inc. — 1.56%
  11. Cardinal Health, Inc. — 1.51%

Only in HRTS

  1. Roche Holding AG — 4.50%
  2. Gilead Sciences Inc — 3.43%
  3. Revolution Medicines Inc — 3.33%
  4. Vertex Pharmaceuticals Inc — 2.93%
  5. Bridgebio Pharma Inc — 2.59%
  6. Cytokinetics Inc — 2.52%
  7. Teva Pharmaceutical Industries — 2.06%
  8. Dexcom Inc — 1.92%
  9. Amgen Inc — 1.91%
  10. Medtronic PLC — 1.88%
  11. McKesson Corp — 1.71%

Asset mix

Asset typeJDOCHRTS
Stocks99.2%99.2%
Cash & short-term funds—0.7%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryJDOCHRTS
US75.2%74.9%
CH4.4%7.9%
DK4.0%7.0%
GB6.2%4.0%
JP2.5%1.3%
NL2.4%—
IL1.6%2.1%
IE0.4%1.9%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do JDOC and HRTS overlap?
About 56% by weight. 14 securities appear in both funds' top 25 holdings; they make up 55.0% of JDOC's assets and 54.4% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do JDOC and HRTS have in common?
The largest shared holdings are Eli Lilly & Co., UnitedHealth Group, Inc., Merck & Co., Inc., AstraZeneca plc, Thermo Fisher Scientific, Inc..
Should I own both JDOC and HRTS?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, JDOC or HRTS?
JDOC is broader, with 61 positions versus 45 for HRTS. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.